|
1
|
Saunders M and Iveson T: Management of
advanced colorectal cancer: state of the art. Br J Cancer.
95:131–138. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
3
|
Din FV, Theodoratou E, Farrington SM,
Tenesa A, Barnetson RA, Cetnarskyj R, et al: Effect of aspirin and
NSAIDs on risk and survival from colorectal cancer. Gut.
59:1670–1679. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang D and Dubois RN: The role of COX-2 in
intestinal inflammation and colorectal cancer. Oncogene.
29:781–788. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lakatos PL and Lakatos L: Risk for
colorectal cancer in ulcerative colitis: changes, causes and
management strategies. World J Gastroenterol. 14:3937–3947. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Strell C, Rundqvist H and Ostman A:
Fibroblasts - a key host cell type in tumor initiation,
progression, and metastasis. Ups J Med Sci. 117:187–195. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Benson V, McMahon AC and Lowe HC: ICAM-1
in acute myocardial infarction: a potential therapeutic target.
Curr Mol Med. 7:219–227. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Niessen HW, Lagrand WK, Visser CA, Meijer
CJ and Hack CE: Upregulation of ICAM-1 on cardiomyocytes in
jeopardized human myocardium during infarction. Cardiovasc Res.
41:603–610. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang WC, Chan ST, Yang TL, Tzeng CC and
Chen CC: Inhibition of ICAM-1 gene expression, monocyte adhesion
and cancer cell invasion by targeting IKK complex: molecular and
functional study of novel α-methylene-γ-butyrolactone derivatives.
Carcinogenesis. 25:1925–1934. 2004.PubMed/NCBI
|
|
10
|
van de Stolpe A and van der Saag PT:
Intercellular adhesion molecule-1. J Mol Med. 74:13–33. 1996.
|
|
11
|
Ksiazek K, Mikula-Pietrasik J, Catar R,
Dworacki G, Winckiewicz M, Frydrychowicz M, et al: Oxidative
stress-dependent increase in ICAM-1 expression promotes adhesion of
colorectal and pancreatic cancers to the senescent peritoneal
mesothelium. Int J Cancer. 127:293–303. 2010.
|
|
12
|
Arteta B, Lasuen N, Lopategi A,
Sveinbjörnsson B, Smedsrød B and Vidal-Vanaclocha F: Colon
carcinoma cell interaction with liver sinusoidal endothelium
inhibits organ-specific antitumor immunity through
interleukin-1-induced mannose receptor in mice. Hepatology.
51:2172–2182. 2010. View Article : Google Scholar
|
|
13
|
Alexiou D, Karayiannakis AJ, Syrigos KN,
Zbar A, Kremmyda A, Bramis I and Tsigris C: Serum levels of
E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients:
correlations with clinicopathological features, patient survival
and tumour surgery. Eur J Cancer. 37:2392–2397. 2001. View Article : Google Scholar
|
|
14
|
Maeda K, Kang SM, Sawada T, Nishiguchi Y,
Yashiro M, Ogawa Y, et al: Expression of intercellular adhesion
molecule-1 and prognosis in colorectal cancer. Oncol Rep.
9:511–514. 2002.PubMed/NCBI
|
|
15
|
Mantur M, Snarska J, Koper O, Dzieciol J,
Plonski A and Lemancewicz D: Serum sICAM, sVCAM and sE-selectin
levels in colorectal cancer patients. Folia Histochem Cytobiol.
47:621–625. 2009.PubMed/NCBI
|
|
16
|
Taglia L, Matusiak D, Matkowskyj KA and
Benya RV: Gastrin-releasing peptide mediates its morphogenic
properties in human colon cancer by upregulating intracellular
adhesion protein-1 (ICAM-1) via focal adhesion kinase. Am J Physiol
Gastrointest Liver Physiol. 292:G182–G190. 2007. View Article : Google Scholar
|
|
17
|
Wimmenauer S, Keller H, Rückauer KD,
Rahner S, Wolff-Vorbeck G, Kirste G, et al: Expression of CD44,
ICAM-1 and N-CAM in colorectal cancer. Correlation with the tumor
stage and the phenotypical characteristics of tumor-infiltrating
lymphocytes. Anticancer Res. 17:2395–2400. 1997.
|
|
18
|
Kitagawa T, Matsumoto K and Iriyama K:
Serum cell adhesion molecules in patients with colorectal cancer.
Surg Today. 28:262–267. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sanchez-Rovira P, Jimenez E, Carracedo J,
Barneto IC, Ramirez R and Aranda E: Serum levels of intercellular
adhesion molecule 1 (ICAM-1) in patients with colorectal cancer:
inhibitory effect on cytotoxicity. Eur J Cancer. 34:394–398. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kang X, Wang F, Xie JD, Cao J and Xian PZ:
Clinical evaluation of serum concentrations of intercellular
adhesion molecule-1 in patients with colorectal cancer. World J
Gastroenterol. 11:4250–4253. 2005.PubMed/NCBI
|
|
21
|
Alexiou D, Karayiannakis AJ, Syrigos KN,
Zbar A, Sekara E, Michail P, et al: Clinical significance of serum
levels of E-selectin, intercellular adhesion molecule-1, and
vascular cell adhesion molecule-1 in gastric cancer patients. Am J
Gastroenterol. 98:478–485. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakata B, Hori T, Sunami T, Ogawa Y,
Yashiro M, Maeda K, et al: Clinical significance of serum soluble
intercellular adhesion molecule 1 in gastric cancer. Clin Cancer
Res. 6:1175–1179. 2000.PubMed/NCBI
|
|
23
|
Zhang GJ and Adachi I: Serum levels of
soluble intercellular adhesion molecule-1 and E-selectin in
metastatic breast carcinoma: Correlations with clinicopathological
features and prognosis. Int J Oncol. 14:71–77. 1999.
|
|
24
|
O'Hanlon DM, Fitzsimons H, Lynch J, Tormey
S, Malone C and Given HF: Soluble adhesion molecules (E-selectin,
ICAM-1 and VCAM-1) in breast carcinoma. Eur J Cancer. 38:2252–2257.
2002. View Article : Google Scholar
|
|
25
|
Silva HC, Garcao F, Coutinho EC, De
Oliveira CF and Regateiro FJ: Soluble VCAM-1 and E-selectin in
breast cancer: relationship with staging and with the detection of
circulating cancer cells. Neoplasma. 53:538–543. 2006.PubMed/NCBI
|
|
26
|
Perabo F, Sharma S, Gierer R, Wirger A,
Fimmers R, Steiner G, et al: Circulating intercellular adhesion
molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and
E-selectin in urological malignancies. Indian J Cancer. 38:1–7.
2001.PubMed/NCBI
|
|
27
|
Harning R, Mainolfi E, Bystryn JC, Henn M,
Merluzzi VJ and Rothlein R: Serum levels of circulating
intercellular adhesion molecule 1 in human malignant melanoma.
Cancer Res. 51:5003–5005. 1991.PubMed/NCBI
|
|
28
|
Grothey A, Heistermann P, Philippou S and
Voigtmann R: Serum levels of soluble intercellular adhesion
molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung
cancer: correlation with histological expression of ICAM-1 and
tumour stage. Br J Cancer. 77:801–807. 1998. View Article : Google Scholar
|
|
29
|
Shimizu Y, Minemura M, Tsukishiro T,
Kashii Y, Miyamoto M, Nishimori H, et al: Serum concentration of
intercellular adhesion molecule-1 in patients with hepatocellular
carcinoma is a marker of the disease progression and prognosis.
Hepatology. 22:525–531. 1995.PubMed/NCBI
|
|
30
|
Christiansen I, Sundström C and Tötterman
TH: Elevated serum levels of soluble vascular cell adhesion
molecule-1 (sVCAM-1) closely reflect tumour burden in chronic
B-lymphocytic leukaemia. Br J Haematol. 103:1129–1137. 1998.
View Article : Google Scholar
|
|
31
|
Jackson AM, Alexandrov AB, Gribben SC,
Esuvarnathan K and James K: Expression and shedding of ICAM-1 in
bladder cancer and its immunotherapy. Int J Cancer. 55:921–925.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Budnik A, Grewe M, Gyufko K and Krutmann
J: Analysis of the production of soluble ICAM-1 molecules by human
cells. Exp Hematol. 24:352–359. 1996.PubMed/NCBI
|
|
33
|
Franzke A, Probst-Kepper M, Buer J,
Duensing S, Hoffmann R, Wittke F, et al: Elevated pretreatment
serum levels of soluble vascular cell adhesion molecule 1 and
lactate dehydrogenase as predictors of survival in cutaneous
metastatic malignant melanoma. Br J Cancer. 78:40–45. 1998.
View Article : Google Scholar
|
|
34
|
Schellerer VS, Croner RS, Weinländer K,
Hohenberger W, Stürzl M and Naschberger E: Endothelial cells of
human colorectal cancer and healthy colon reveal phenotypic
differences in culture. Lab Invest. 87:1159–1170. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Desmoulière A, Guyot C and Gabbiani G: The
stroma reaction myofibroblast: a key player in the control of tumor
cell behavior. Int J Dev Biol. 48:509–517. 2004.PubMed/NCBI
|
|
36
|
Gonda TA, Varro A, Wang TC and Tycko B:
Molecular biology of cancer-associated fibroblasts: can these cells
be targeted in anti-cancer therapy? Semin Cell Dev Biol. 21:2–10.
2010. View Article : Google Scholar : PubMed/NCBI
|
